Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

FDA APPROVES TESTS OF IMRE'S PROSORBA

Aug. 6, 1991

MERGER TO COST $350M IN CHARGES

Aug. 5, 1991

SOMATOGEN STOCK UP AFTER IPO

Aug. 5, 1991

hGH APPROVAL SOUGHT FOR JAPAN

Aug. 5, 1991

MYCOGEN ACQUIRES CROP-PROTECTION COMPANY

Aug. 5, 1991

APPOINTMENTS AND ADVANCEMENTS

Aug. 5, 1991

INVITRON SCHEDULES SHAREHOLDERS PAYMENT

Aug. 5, 1991

RIBI COMPLETES PRIVATE PLACEMENT

Aug. 5, 1991

ANTISENSE USED TO HALT LEUKEMIA

Aug. 2, 1991

PATENT TRIAL DRIVES STOCK RATINGS

Aug. 2, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...